Revenue: The sum of all revenue fields included for a company's operating activities.
eFFECTOR Therapeutics, Inc. (EFTR) Revenue data is not available for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-35.81M |
|
-- |
|
-- |
|
$33.84M |
|
$-33.84M |
|
$-1.97M |
|
$-35.81M |
|
$-35.81M |
|
$-35.81M |
|
$-35.81M |
|
$-35.81M |
|
$-35.81M |
|
$-33.84M |
|
$-34.21M |
|
2.19M |
|
2.19M |
|
$-16.37 |
|
$-16.37 |
|
| Balance Sheet Financials | |
$19.84M |
|
$0.14M |
|
$0.71M |
|
$20.54M |
|
$25.80M |
|
-- |
|
$0.54M |
|
$26.34M |
|
$-5.79M |
|
$-5.79M |
|
$-5.79M |
|
2.98M |
|
| Cash Flow Statement Financials | |
$-29.55M |
|
$14.48M |
|
$21.23M |
|
$8.71M |
|
$14.88M |
|
$6.17M |
|
$4.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.77 |
|
-- |
|
-- |
|
-- |
|
-3.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.65M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
617.96% |
|
617.96% |
|
-174.31% |
|
617.96% |
|
$-1.94 |
|
$-13.56 |
|
$-13.51 |
|